Program Schedule

Interventions to Treat End Organ Disease in HIV Care

Saturday, October 11, 2014: 10:30 AM-12:00 PM
Room: The Pennsylvania Convention Center: 120-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the use of anti-inflammatories in the management of patients with HIV
  • identify current and future statins effective at preventing end organ disease
  • describe new organ transplantation opportunities for patients with HIV

Target Audience: Public health practitioners, Members-in-training, Infectious diseases physicians, HIV specialists, HIV clinicians, Fellows, Clinicians

Tracks: HIV-STD-TB

Moderator:  Pablo Tebas, MD, Perelman School of Medicine, University of Pennsylvania

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-143-L02-P


P. Tebas, None

P. Hsue, Gilead: received honoraria, Speaker honorarium

T. Overton, Gilead Sciences: Scientific Advisor, Consulting fee
Janssen Pharmaceuticals: Scientific Advisor, Consulting fee

C. Durand, Gilead: Investigator and Scientific Advisor, institution received support for clinical trial on which I am site Principal Investigator

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek